Yong S Chang Selected Research

Yong S Chang Research Topics

Disease

7	Tuberculosis (Tuberculoses) 04/2023 - 01/2017
7	Neoplasms (Cancer) 01/2023 - 04/2007
3	Infections 01/2018 - 11/2016
2	Latent Tuberculosis 04/2023 - 01/2023
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020
1	Meningeal Tuberculosis (Tuberculous Meningitis) 12/2018
1	Granuloma 01/2018
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2017
1	Inflammation (Inflammations) 01/2017
1	Persistent Infection 11/2016
1	Carcinogenesis 01/2016
1	Hypoxia (Hypoxemia) 04/2007
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2007

Drug/Important Bio-Agent (IBA)

2	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 04/2023 - 01/2023
2	rifapentine (Priftin)FDA Link 04/2023 - 01/2023
2	Rifabutin (Ansamycin)FDA Link 04/2023 - 01/2023
2	Rifampin (Rifampicin)FDA LinkGeneric 12/2018 - 01/2018
2	AntibodiesIBA 01/2018 - 01/2016
2	Pyrazinamide FDA LinkGeneric 01/2018 - 01/2017
1	Lysine-tRNA LigaseIBA 10/2022
1	Linezolid (Zyvox)FDA Link 01/2020
1	pretomanidIBA 01/2020
1	bedaquiline (R207910)IBA 01/2020
1	AerosolsIBA 01/2018
1	Etanercept (Enbrel)FDA Link 01/2018
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2018
1	ZincIBA 01/2018
1	Matrix Metalloproteinases (MMPs)IBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	FluorineIBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2016
1	Anti-Infective Agents (Microbicides)IBA 11/2016
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 11/2016
1	caprolactoneIBA 11/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	CytokinesIBA 01/2016
1	Gefitinib (Iressa)FDA Link 01/2016
1	Trastuzumab (Herceptin)FDA Link 01/2016
1	ATSP-7041IBA 09/2013
1	Proteins (Proteins, Gene)FDA Link 09/2013
1	Peptides (Polypeptides)IBA 09/2013
1	Carbonic Anhydrase IXIBA 02/2012
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 02/2012
1	BAY 79-4620IBA 02/2012
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 02/2011
1	Insulin-Like Growth Factor I (IGF-1)IBA 02/2011
1	Neutralizing AntibodiesIBA 02/2011
1	dusigitumabIBA 02/2011
1	Sorafenib (BAY 43-9006)FDA Link 04/2007
1	Histones (Histone)IBA 04/2007
1	Capsules (Microcapsules)IBA 04/2007
1	Phosphotransferases (Kinase)IBA 04/2007
1	Fluorescein-5-isothiocyanate (FITC)IBA 04/2007
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 04/2007
1	tyrosine receptor (receptor, tyrosine)IBA 04/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2007
1	pimonidazoleIBA 04/2007
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 04/2007

Therapy/Procedure

5	Therapeutics 04/2023 - 02/2011
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2016
1	Prostheses and Implants (Prosthesis) 11/2016